Virbac SA
Virbac SA (VRBCF) Financial Performance & Income Statement Overview
Explore the financials of Virbac SA (VRBCF), including yearly and quarterly data on income, cash flow, and balance sheets.
Virbac SA (VRBCF) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Virbac SA VRBCF financial performance.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $0.00 | $702.93M | $318.22M | $318.22M |
| Cost of Revenue | $0.00 | $220.12M | $113.21M | $113.21M |
| Gross Profit | $0.00 | $482.81M | $205.005M | $205.005M |
| Gross Profit Ratio | $0.00 | $0.69 | $0.64 | $0.64 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $302.55M | $151.22M | $151.22M |
| Operating Expenses | -$108.55M | $374.29M | $167.27M | $172.55M |
| Total Costs & Expenses | -$108.55M | $559.06M | $280.48M | $285.76M |
| Interest Income | $0.00 | $0.00 | $4.60M | $65000.00 |
| Interest Expense | $0.00 | $0.00 | $5.004M | $0.00 |
| Depreciation & Amortization | $31.27M | $25.97M | $8.79M | $8.79M |
| EBITDA | $96.16M | $168.70M | $47.91M | $47.91M |
| EBITDA Ratio | $0.24 | $0.15 | $0.15 | |
| Operating Income | $108.55M | $143.88M | $37.74M | $39.12M |
| Operating Income Ratio | $0.20 | $0.12 | $0.12 | |
| Other Income/Expenses (Net) | -$108.67M | -$1.68M | -$5.35M | -$5.35M |
| Income Before Tax | -$118000.00 | $142.20M | $32.39M | $32.39M |
| Income Before Tax Ratio | $0.20 | $0.10 | $0.10 | |
| Income Tax Expense | -$50.90M | $47.32M | $9.23M | $9.23M |
| Net Income | $50.62M | $94.67M | $23.13M | $23.26M |
| Net Income Ratio | $0.13 | $0.07 | $0.07 | |
| EPS | $6.04 | $11.31 | $2.77 | $2.77 |
| Diluted EPS | $6.04 | $11.29 | $2.75 | $2.76 |
| Weighted Avg Shares Outstanding | $8.37M | $8.37M | $8.36M | $8.41M |
| Weighted Avg Shares Outstanding (Diluted) | $8.37M | $8.38M | $8.42M | $8.42M |
Over the last four quarters, Virbac SA's revenue moved from $318.22M in Q3 2023 to $0.00 in Q4 2024. Operating income in Q4 2024 was $108.55M, with a strong operating margin of N/A. Despite fluctuations in R&D and SG&A expenses, EBITDA for Virbac SA remained robust at $96.16M, reflecting operational efficiency. Net income dropped to $50.62M, with an EPS of $6.04. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan